Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-10-06

Sana Biotechnology (SANA)

CEO Steven Harr was paid $2,903,010 in fiscal year 2025, ↓ down 67.0% from fiscal year 2024 (SEC filing 0001193125-26-174883 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$2,903,010 ↓
Steven Harr total, FY2025
—
CEO pay percentile vs peers
—
CEO-to-median pay ratio
—
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Steven Harr (President, Chief Executive Officer, and Director), FY2025 total compensation $2,903,010 (base salary $696,140) [exec_comp, SEC accession 0001193125-26-174883, filed 2026-04-24]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

SANA's next annual pay disclosure, estimated April 23, 2027.est. Filing ↗

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Steven Harr$696,140$0$425,001$1,327,500$450,369$0$4,000$2,903,010
President, Chief Executive Officer, and Director
Bernard Cassidy404,0340135,999424,8000051,2801,016,113
Former Executive Vice President, General Counsel, and Corporate Secretary

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Steven Harr$2,903,010$8,788,580$2,671,662↓ −5,885,570
Bernard Cassidy1,016,1132,345,597987,382↓ −1,329,484

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read Sana Biotechnology's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper SANA reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

How we handle your data → Privacy

Companies that benchmark against SANA
8 companies name SANA as a compensation peer

Each company listed discloses SANA in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named SANA in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2025 total
Alise S. Reicin, M.DIndependent Director$170,287
Douglas Cole, M.DFormer director (through FY2025)$20,488
Hans E. BishopChair of the Board$220,515
Joshua H. Bilenker, M.DIndependent Director$169,517
Mary Agnes (Maggie) WilderotterFormer director (through FY2025)$162,570
Michelle Seitz, CFAIndependent Director$182,787
Patrick Y. Yang, Ph.DIndependent Director$167,787
Richard Mulligan, Ph.DDirector$162,787
Robert L. RosielloIndependent Director$230,696
Robert NelsenIndependent Director$162,787
02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Robert NelsenDirector2026-06-04A90,000$0$0Derivative, Class A CommonForm 4 ↗
Joshua H. BilenkerDirector2026-06-04A90,00000Derivative, Class A CommonForm 4 ↗
Hans E. BishopDirector2026-06-04A90,00000Derivative, Class A CommonForm 4 ↗
Alise ReicinDirector2026-06-04A90,00000Derivative, Class A CommonForm 4 ↗
Michelle SeitzDirector2026-06-04A90,00000Derivative, Class A CommonForm 4 ↗
Robert L. RosielloDirector2026-06-04A90,00000Derivative, Class A CommonForm 4 ↗
Patrick Y. YangDirector2026-06-04A90,00000Derivative, Class A CommonForm 4 ↗
Richard MulliganDirector2026-06-04A90,00000Derivative, Class A CommonForm 4 ↗
Hans E. BishopDirector2026-07-06A6,29700CommonForm 4 ↗
Dhavalkumar Dhirajlal PatelEVP, Chief Scientific Officer2026-08-26D125,00000Derivative, Class A CommonForm 4 ↗
Dhavalkumar Dhirajlal PatelEVP, Chief Scientific Officer2026-08-26A125,00000CommonForm 4 ↗
Dhavalkumar Dhirajlal PatelEVP, Chief Scientific Officer2026-08-27D41,1584169,159CommonForm 4 ↗
Hans E. BishopDirector2026-10-05A8,68000CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Steven HarrRSU—————$425,001
Steven HarrOPTION—————1,327,500
Bernard CassidyRSU—————135,999
Bernard CassidyOPTION—————424,800
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Steven Harr$425,001$0$1,327,5000.0%
Bernard Cassidy135,9990424,8000.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Bernard CassidyRSU53,333—$217,065
Bernard CassidyRSU33,126—134,823
Steven HarrRSU150,000—610,500
Steven HarrRSU166,667—678,335
Bernard CassidyOption240,0002.55—
Steven HarrOption47,5005.7—
Steven HarrOption203,1253.76—
Steven HarrOption750,0002.55—
Steven HarrOption506,2509.58—
Bernard CassidyOption150,0007.13—
Bernard CassidyOption43,7503.76—
Bernard CassidyOption111,7979.58—
05

Incentive-plan design — the Compensation Discussion & Analysis

We have a pay-for-performance focused executive compensation philosophy. We believe that compensation should be designed to drive company performance to increase stockholder value. We seek to achieve this by using different elements of compensation and a market-based approach to attract, retain, and motivate a high-performing team of executive officers, and by aligning a majority of the compensation of each of our executives with the company's short- and long-term performance.

CEO STI target (% of salary)60%
CEO LTI target (% of salary)—
Independent consultantAon plc (Human Capital Solutions practice)
Clawback policyTrue
Anti-hedgingTrue
Anti-pledgingTrue
07

CEO pay ratio

Ratio (CEO : median employee)—
CEO total compensation—
Median employee compensation—
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Robert L. RosielloIndependent · Audit · Compensation and Talent$30,119$0$200,577$0$0$230,696
Hans E. BishopIndependent · Board Chair · Audit · Compensation and Talent (Chair)97,7270122,7870—220,515
Michelle Seitz, CFAIndependent · Audit (Chair)60,0000122,78700182,787
Alise S. Reicin, M.DIndependent · Compensation and Talent47,5000122,78700170,287
Joshua H. Bilenker, M.DIndependent · Nominating and Corporate Governance (Chair)46,7290122,7870—169,517
Patrick Y. Yang, Ph.DIndependent · Nominating and Corporate Governance45,0000122,78700167,787
Robert NelsenIndependent40,0000122,78700162,787
Richard Mulligan, Ph.DNot independent40,0000122,78700162,787
Mary Agnes (Maggie) WilderotterIndependent · Audit · Nominating and Corporate Governance (Chair) · Departed during FY39,7830122,78700162,570
Douglas Cole, M.DIndependent · Compensation and Talent · Departed during FY20,488000020,488
Steven D. Harr, M.DEmployee director000—00
09

Board fee structure and ownership guideline

Annual cash retainer$40,000
Annual equity retainer$122,787
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)10,000 / 35,000 / 5,000
Stock ownership guideline—
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$467,346
Equity awards (grant-date value)$0
All other compensation$0
Total cost of the board$467,346

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Sana Biotechnology2025Steven Harr$696,140$425,001$1,327,500$450,369$2,903,010

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10d

Frequently asked questions

Who was the highest-paid executive at Sana Biotechnology in fiscal 2025?
As disclosed, Steven Harr (President, Chief Executive Officer, and Director) was the highest-paid executive at Sana Biotechnology in fiscal 2025, with total compensation of $2,903,010.
How much does Sana Biotechnology spend in total on board compensation for fiscal 2025?
As disclosed, Sana Biotechnology reported total board compensation of $467,346 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Steven HarrDEF 14A2026-04-240001193125-26-174883Section “Summary Compensation Table” · page 25. As printed: 2,903,010. Filing ↗machine: t69 · r3 · c27 · span 235773–235782
2Section 01, Bernard CassidyDEF 14A2026-04-240001193125-26-174883Section “Summary Compensation Table” · page 25. As printed: 1,016,113. Filing ↗machine: t69 · r6 · c27 · span 241348–241357
3Section 03, Steven Harr RSUDEF 14A2026-04-240001193125-26-174883Section “EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t69 · r3 · c11 · span 234737–234744
4Section 03, Steven Harr OPTIONDEF 14A2026-04-240001193125-26-174883Section “EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t69 · r3 · c15 · span 234996–235005
5Section 03, Bernard Cassidy RSUDEF 14A2026-04-240001193125-26-174883Section “EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t69 · r6 · c11 · span 240257–240264
6Section 03, Bernard Cassidy OPTIONDEF 14A2026-04-240001193125-26-174883Section “EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t69 · r6 · c15 · span 240516–240523
7Section 07, pay ratio10-K2026-03-030001193125-26-088215Section “CEO Pay Ratio”. As printed: —. Filing ↗
8Section 08, Robert L. RosielloDEF 14A2026-04-240001193125-26-174883Section “Director Compensation”. As printed: 230,696. Filing ↗machine: t100 · r8 · c11 · span 375225–375232
9Section 08, Hans E. BishopDEF 14A2026-04-240001193125-26-174883Section “Director Compensation”. As printed: 220,515. Filing ↗machine: t100 · r3 · c11 · span 369691–369698
10Section 08, Michelle Seitz, CFADEF 14A2026-04-240001193125-26-174883Section “Director Compensation”. As printed: 182,787. Filing ↗machine: t100 · r9 · c11 · span 376295–376302
11Section 08, Alise S. Reicin, M.DDEF 14A2026-04-240001193125-26-174883Section “Director Compensation”. As printed: 170,287. Filing ↗machine: t100 · r7 · c11 · span 374075–374082
12Section 08, Joshua H. Bilenker, M.DDEF 14A2026-04-240001193125-26-174883Section “Director Compensation”. As printed: 169,517. Filing ↗machine: t100 · r2 · c11 · span 368570–368577
13Section 08, Patrick Y. Yang, Ph.DDEF 14A2026-04-240001193125-26-174883Section “Director Compensation”. As printed: 167,787. Filing ↗machine: t100 · r11 · c11 · span 378475–378482
14Section 08, Robert NelsenDEF 14A2026-04-240001193125-26-174883Section “Director Compensation”. As printed: 162,787. Filing ↗machine: t100 · r6 · c11 · span 373003–373010
15Section 08, Richard Mulligan, Ph.DDEF 14A2026-04-240001193125-26-174883Section “Director Compensation”. As printed: 162,787. Filing ↗machine: t100 · r5 · c11 · span 371914–371921
16Section 08, Mary Agnes (Maggie) WilderotterDEF 14A2026-04-240001193125-26-174883Section “Director Compensation”. As printed: 162,570. Filing ↗machine: t100 · r10 · c11 · span 377402–377409
17Section 08, Douglas Cole, M.DDEF 14A2026-04-240001193125-26-174883Section “Director Compensation”. As printed: 20,488. Filing ↗machine: t100 · r4 · c3 · span 370262–370268
18Section 08, Steven D. Harr, M.DDEF 14A2026-04-240001193125-26-174883Section “Director Compensation”. As printed: 0. Filing ↗
19Section 02, Robert Nelsen 2026-06-04Form 42026-06-050001770121-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
20Section 02, Joshua H. Bilenker 2026-06-04Form 42026-06-050001612312-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
21Section 02, Hans E. Bishop 2026-06-04Form 42026-06-050001480212-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
22Section 02, Alise Reicin 2026-06-04Form 42026-06-050001757533-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
23Section 02, Michelle Seitz 2026-06-04Form 42026-06-050001836301-26-000014Insider equity transaction reported since the proxy statement. Filing ↗
24Section 02, Robert L. Rosiello 2026-06-04Form 42026-06-050001645041-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
25Section 02, Patrick Y. Yang 2026-06-04Form 42026-06-050001309988-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
26Section 02, Richard Mulligan 2026-06-04Form 42026-06-050001376247-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
27Section 02, Hans E. Bishop 2026-07-06Form 42026-07-070001480212-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
28Section 02, Dhavalkumar Dhirajlal Patel 2026-08-26Form 42026-08-270002115339-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
29Section 02, Dhavalkumar Dhirajlal Patel 2026-08-26Form 42026-08-270002115339-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
30Section 02, Dhavalkumar Dhirajlal Patel 2026-08-27Form 42026-08-270002115339-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
31Section 02, Hans E. Bishop 2026-10-05Form 42026-10-060001480212-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
32Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
33Section 03b vehicle mix (computed)Computed——RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
34Section 09b board cost (computed)Computed——Cash 467,346 + equity 0 + all other 0 = 467,346, summed across the director compensation table rows.machine: formula: Σ = 467,346
35Sana Biotechnology (subject), Section 10b CEO totalDEF 14A2026-04-240001193125-26-174883CEO total compensation as printed in Sana Biotechnology's own proxy. As printed: 2,903,010. Filing ↗machine: t69 · r3 · c27 · span 235773–235782

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.